BCL2 and ovarian carcinoma: Furthermore, in paclitaxel-resistant ovarian cancer cells, the combination of EGCG and sulforaphane treatment induced apoptosis and cell cycle arrest by damaging DNA and decreasing the expression of Bcl-2 and human telomerase reverse transcriptase (hTERT), the major catalytic subunit of telomerase, which was involved in cancer cell survival.